HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dermapharm AG


Latest From Dermapharm AG

Dermapharm Expands International Herbals And Supplements Capacity With Two Acquisitions

German generics and OTC specialist Dermapharm has snapped up two firms that it said would enable it to boost its international presence. 
Health OTC Drugs

Germany Begins The Year With Two Possible Rx-To-OTC Switches

Germany's Expert Committee for Prescription will meet on 22 January to consider two prescription-to-OTC switch applications: preparations containing a combination of ibuprofen and phenylephrine hydrochloride and hydrocortisone 1% for external use. 
Health OTC Drugs

Finance Watch: Biopharma IPOs Defy Broader Stock Performance Trends

Public Company Edition: With returns for newly public biopharma companies rising, seven more jumped in line to go public in the US between the beginning of February and early March, while two drug developers launched IPOs in the EU. Meanwhile, already public companies keep raising gobs of cash.

Financing Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Dermapharm AG
  • Senior Management
  • Contact Info
  • Dermapharm AG
    Phone: (49) 89 6 41 86-0
    Luise-Ullrichstrasse 6
    Gruenwald, 82031